# APHEXDA

NDC: 73441-062
Generic name: MOTIXAFORTIDE
Labeler / Manufacturer: Gamida Cell Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20250615

FDA application: NDA217159

## Active ingredients

- MOTIXAFORTIDE ACETATE: 62 mg/1.7mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"73441-062"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=73441-062
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e704b2db-f119-40ba-9346-9229e3281c9e